Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 17 de 17
1.
Cryobiology ; 71(3): 472-80, 2015 Dec.
Article En | MEDLINE | ID: mdl-26408850

A simple method to cryopreserve adherent monolayers of neuronal cells is currently not available, but the development of this technique could facilitate numerous applications in the field of biomedical engineering, cell line development, and drug screening. However, complex tissues of some exceptional animals survive freezing in nature. These animals are known to accumulate several small molecular weight solutes prior to freezing. Following a similar strategy, we investigated the effects of osmolytes such as trehalose, proline, and sucrose as additives to the traditional cryoprotectant dimethyl sulfoxide (Me2SO) in modulating the cryopreservation outcome of mouse neuroblastoma (Neuro-2a) cells. Neuro-2a cells adhered to cell culture plates were incubated for 24 h at varying concentrations of trehalose, proline, sucrose and combinations of these compounds. Cells were cryopreserved for 24 h and cell viability post-freezing and thawing was quantified by trypan blue exclusion assay. On average, only 13.5% of adherent cells survived freezing in the presence of 10% Me2SO alone (control). Pre-incubation of cells with medium containing both trehalose and proline severely decreased cell proliferation, but increased cell recovery to about 53% of control. Furthermore, characterization using Raman microspectroscopy revealed that the addition of both trehalose and proline to 10% Me2SO substantially increased the size, and altered the nature, of ice crystals formed during freezing. Our results suggest that pre-incubation of Neuro-2a cells with trehalose and proline in combination provides cell protection along with alterations of ice structure in order to increase cell survival post-freezing.


Cryopreservation/methods , Cryoprotective Agents/pharmacology , Neuroblastoma , Proline/pharmacology , Trehalose/pharmacology , Animals , Cell Culture Techniques , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Dimethyl Sulfoxide/pharmacology , Mice , Sucrose/pharmacology
2.
Brain Res ; 1624: 19-27, 2015 Oct 22.
Article En | MEDLINE | ID: mdl-26206299

Olfactory deficits are observed early in the course of chronic neurological disorders including Alzheimer's disease (AD). Estrogen treatment in post-menopausal women reduced the incidence of olfactory dysfunction, raising the possibility that estrogen treatment can cure olfactory deficits in preclinical stages of AD. In this study, we examined the estradiol׳s effects on neurite outgrowth in explant cultures of mouse olfactory epithelium (OE). We found that neurons in OE cultures treated with 100 pM 17-ß estradiol (estradiol) had significantly longer neurite outgrowth than cultures treated with ethanol alone (vehicle). The OE neurons expressed estrogen receptors alpha (ERα) and ER beta (ERß). Estrogen treatment upregulated both ERα and ERß expression in OE culture. Treatment of OE cultures with propyl pyrazole triol (PPT), a selective agonist for ERα increased neurite outgrowth to comparable extent as estradiol treatment. In contrast, 2,3-bis-4-hydroxyphenyl (DPN), a specific agonist for ERß, had no effect on neurite outgrowth. Furthermore, estradiol treatment increased neurite outgrowth in OE cultures derived from ERß-deficient/knockout mice and wild-type littermates, but not in ERα-deficient/knockout mice. These data suggest that ERα mediates the neurite outgrowth promoting effects of estradiol in OE cultures. We propose that olfactory dysfunction in chronic neurological disorders, where estrogen deficiency is a risk factor, is an indicator of compromised axonal regeneration of olfactory sensory neurons.


Estradiol/pharmacology , Estrogen Receptor alpha/metabolism , Neurites/drug effects , Neurons/cytology , Olfactory Mucosa/cytology , Animals , Animals, Newborn , Cells, Cultured , Estrogen Receptor alpha/genetics , Estrogen Receptor beta/deficiency , Estrogen Receptor beta/genetics , Female , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Ginsenosides/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , NAD/pharmacology , Neurons/drug effects , Sapogenins/pharmacology
3.
J Biomed Sci ; 20: 49, 2013 Jul 12.
Article En | MEDLINE | ID: mdl-23845000

BACKGROUND: The apolipoprotein E4 (apoE4) genotype is a major risk factor for developing late-onset Alzheimer's disease (AD). Inheritance of apoE4 is also associated with impairments in olfactory function in early stages of AD. In this project we examined the effects of the three common isoforms of human apoE (apoE2, apoE3, and apoE4) on neuronal differentiation and neurite outgrowth in explant cultures of mouse olfactory epithelium (OE). RESULTS: The OE cultures derived from apoE-deficient/knockout (KO) mice have significantly fewer neurons with shorter neurite outgrowth than cultures from wild-type (WT) mice. Treatment of the apoE KO culture with either purified human apoE2 or with human apoE3 significantly increased neurite outgrowth. In contrast, treatment with apoE4 did not have an effect on neurite outgrowth. The differential effects of human apoE isoforms on neurite outgrowth were abolished by blocking the low-density lipoprotein receptor-related protein (LRP) with lactoferrin and receptor-associated protein (RAP). CONCLUSION: ApoE2 and apoE3 stimulate neurite outgrowth in OE cultures by interacting with the lipoprotein receptor, LRP. ApoE4, the isoform associated with AD, failed to promote neurite outgrowth, suggesting a potential mechanism whereby apoE4 may lead to olfactory dysfunction in AD patients.


Apolipoproteins E/metabolism , Neurites/metabolism , Olfactory Mucosa/metabolism , Animals , Apolipoprotein E2/metabolism , Apolipoprotein E3/metabolism , Apolipoprotein E4/metabolism , Cell Line , Humans , Mice , Mice, Knockout , Olfactory Mucosa/ultrastructure , Protein Isoforms/metabolism
4.
Exp Neurol ; 237(1): 1-7, 2012 Sep.
Article En | MEDLINE | ID: mdl-22691461

Olfactory dysfunction often precedes other clinical symptoms in chronic neurodegenerative diseases like Alzheimer's disease and Parkinson's disease. Estrogen deficiency and apoE genotype are known risk factors in these diseases and these factors also affect olfaction. Therefore we examined the effects of estradiol replacement following ovariectomy on expression of apoE and markers of cell proliferation, neuronal maturation, synaptogenesis and reactive gliosis in the primary olfactory pathway of wild-type (WT) and apoE knockout (KO) mice. Estradiol replacement increased apoE staining in the olfactory nerve and glomerular layers. Estradiol increased astrocyte density and olfactory epithelium (OE) thickness regardless of the genotype. In addition estradiol treatment increased the number of mature neurons in the OE and glomerular synaptophysin in both genotypes, but the magnitude of increase was greater in the WT than in the KO mice. These data suggest that estrogen and apoE act synergistically to minimize the loss of mature sensory neurons and synapses following ovariectomy.


Estradiol/physiology , Olfactory Pathways/metabolism , Olfactory Pathways/physiopathology , Animals , Apolipoproteins E/biosynthesis , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Biomarkers/metabolism , Estradiol/administration & dosage , Estrogen Replacement Therapy , Female , Mice , Mice, Inbred C57BL , Mice, Knockout , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Neurodegenerative Diseases/physiopathology , Olfactory Pathways/pathology , Ovariectomy , Random Allocation , Sensory Receptor Cells/cytology , Sensory Receptor Cells/metabolism , Synapses/pathology , Time Factors
5.
Exp Neurol ; 226(1): 40-6, 2010 Nov.
Article En | MEDLINE | ID: mdl-20696162

ApoE, a protein component of lipoproteins, is extensively expressed in the primary olfactory pathway. Because apoE has been shown to play a vital role in nerve repair and remodeling, we hypothesized that apoE expression will increase in the injured olfactory epithelium (OE), and that apoE deficiency in apoE knockout (KO) mice will lead to delayed/incomplete reconstitution of the OE following injury. To directly test this hypothesis, we compared OE regeneration in wild-type (WT) and KO mice following injury induced by intranasal irrigation of Triton X-100. OE was collected at 0, 3, 7, 21, 42, and 56 days post lesion. The amount and distribution of apoE in the regenerating OE was measured by immunoblotting and immunohistochemistry. Rate of OE reconstitution in WT and KO mice was assessed by using three independent measures: (1) OE thickness was measured in cresyl-violet stained sections, (2) basal cell proliferation was determined by using bromodeoxyuridine (BrdU) staining, and (3) differentiation and maturation of olfactory sensory neurons were measured by immunoblotting and immunohistochemical analysis of growth associated protein (GAP) 43 and olfactory marker protein (OMP). The results revealed that apoE expression in the OE is highly regulated during the entire course of OE reconstitution post injury, and that apoE deficiency in apoE KO mice leads to delayed recovery of mature OMP(+) cells in the reconstituting OE. The data suggest that apoE production increases in the injured OE to facilitate maturation of olfactory sensory neurons.


Apolipoproteins E/genetics , Apolipoproteins E/physiology , Olfactory Mucosa/injuries , Olfactory Mucosa/physiology , Actins/biosynthesis , Animals , Antimetabolites , Blotting, Western , Bromodeoxyuridine , Cell Count , Cell Proliferation , Epithelial Cells/physiology , GAP-43 Protein/biosynthesis , GAP-43 Protein/genetics , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Olfactory Bulb/metabolism , Olfactory Marker Protein/biosynthesis , Olfactory Marker Protein/genetics , Olfactory Mucosa/cytology , Recovery of Function/genetics , Recovery of Function/physiology
6.
Environ Entomol ; 39(3): 892-7, 2010 Jun.
Article En | MEDLINE | ID: mdl-20550803

Because mating may be costly, sexually active males or females are predicted to be in relatively good physiological condition and may preferentially direct their mating behavior toward relatively high-quality mates. We tested this hypothesis in Japanese beetles (Popillia japonica Newman), a pest species in which males and females may be either isolated or in aggregations while feeding on host plants. We examined male size and lipid content and female size and egg load with respect to both their pairing status and whether they were isolated or in aggregations. Males that were paired had the highest lipid levels, and single, isolated males had the lowest. Paired females had the highest egg loads and single, isolated females had the lowest. Neither male nor female size was related to pairing status. Females captured during the times of relatively high pairing frequency (i.e., morning and evening) had higher egg loads than females captured at times of lower pairing frequency (i.e., afternoon). These results suggest that mating and aggregative behaviors in Japanese beetles are dependent on the physiological status of males and the reproductive condition of females.


Coleoptera/physiology , Lipid Metabolism , Oviparity , Sexual Behavior, Animal , Animals , Female , Male , Time Factors
7.
Brain Res ; 1343: 66-74, 2010 Jul 09.
Article En | MEDLINE | ID: mdl-20447382

Epidemiological studies suggest that estrogen therapy protects against clinical expression of chronic neurological diseases. These beneficial effects of estrogen therapy are highly modified by apolipoprotein E (apoE) through an unknown mechanism. We examined the short-term effects of estradiol replacement in ovariectomized mice on apoE expression and markers for cell proliferation, reactive gliosis, neuronal maturation, and synaptogenesis in the primary olfactory pathway of wild-type (WT) and apoE knockout (KO) mice. Three days of estradiol replacement increased apoE expression in the olfactory nerve and in the glomerular layer. Estradiol treatment also increased cell proliferation, total cell numbers, number of mature neurons in the olfactory epithelium, and reactive astrocyte numbers in the olfactory bulb (OB) in both WT and KO mice. We also found that estradiol increased glomerular synaptophysin (Syn), but the magnitude of increase was potentiated by the presence of apoE. These data suggest that apoE may be necessary to elicit the complete effect of estradiol on Syn upregulation.


Apolipoproteins E/genetics , Estradiol/pharmacology , Neurodegenerative Diseases/drug therapy , Olfactory Pathways/drug effects , Animals , Cell Proliferation/drug effects , Estradiol/metabolism , Estradiol/therapeutic use , Gliosis/drug therapy , Gliosis/metabolism , Gliosis/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/physiopathology , Neurogenesis/drug effects , Neurogenesis/physiology , Neuroprotective Agents/metabolism , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Olfactory Bulb/drug effects , Olfactory Bulb/metabolism , Olfactory Bulb/pathology , Olfactory Nerve/drug effects , Olfactory Nerve/metabolism , Olfactory Nerve/pathology , Olfactory Pathways/metabolism , Olfactory Pathways/pathology , Ovariectomy , Up-Regulation/drug effects , Up-Regulation/physiology
8.
Neurosci Lett ; 441(3): 282-5, 2008 Aug 29.
Article En | MEDLINE | ID: mdl-18621483

In this study we examined the role of apoE on the rate of synaptic recovery in the olfactory bulb (OB) following olfactory epithelium (OE) lesioning in mice. We used both immunoblotting and immunohistochemical techniques to compare the density of OB synaptophysin (Syn, a synaptic marker) in apoE-gene deficient/knockout (KO) mice and wild-type (WT) mice following OE lesion. We found that the whole bulb concentrations of Syn, measured by immunoblotting, declined sharply following injury in both WT and KO mice during the degenerative phase (3-7 days). After this initial decline, the Syn concentration gradually increased to normal levels by 56 days in WT mice. In contrast, Syn concentration in KO mice did not recover by day 56 when Syn density in WT was essentially normal. Glomerular Syn density, measured by immunohistochemistry, found a lower density in KO mice at all time points post-lesion. This lower concentration of whole bulb Syn parallels the slower recovery of glomerular area in KO mice. The data indicate that apoE deficiency in KO mice is associated with a delayed recovery of the glomerular area and a slower recovery in Syn concentration in the OB.


Apolipoproteins E/genetics , Nerve Regeneration/physiology , Neuronal Plasticity/physiology , Olfactory Bulb/metabolism , Recovery of Function/physiology , Synaptophysin/metabolism , Animals , Biomarkers/metabolism , Denervation , Disease Models, Animal , Down-Regulation/physiology , Immunoblotting , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neuropil/metabolism , Neuropil/ultrastructure , Olfactory Bulb/cytology , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Time Factors
9.
Front Biosci ; 13: 5387-405, 2008 May 01.
Article En | MEDLINE | ID: mdl-18508594

In this review we examine the evidence for ovarian hormone neuroprotection in chronic neurological diseases, including stroke. We propose that neuroprotection may involve the ability of estrogens to modulate apolipoprotein E (apoE) and its receptor, the low density lipoprotein receptor related protein (LRP). Results from numerous studies have demonstrated that (1) nerve regeneration is severely delayed in apoE-gene knockout (KO) mice as compared to wild-type (WT) littermates; (2) 17beta estradiol replacement in ovariectomized mice resulted in a significant increase in levels of apoE and LRP, in the olfactory bulb (OB) and other brain areas; (3) estradiol treatment increased both apoE and neurite outgrowth in cortical and olfactory neuronal cultures; and (4) estradiol treatment had no effect on neurite outgrowth in cultures deprived of apoE or in the presence of apoE4. In essence these studies suggest that apoE is a critical intermediary for the beneficial effects of 17beta estradiol on nerve repair, which can lead to functional reorganization (plasticity). Future studies of HT should evaluate the effects of apoE genotype and production estradiol on neuroprotection.


Apolipoproteins E/physiology , Hormones/therapeutic use , Neuroprotective Agents , Animals , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Chronic Disease , Dementia/drug therapy , Dementia/physiopathology , Dementia/prevention & control , Estrogen Replacement Therapy , Female , Humans , Menopause/physiology , Menstrual Cycle/physiology , Mice , Mice, Knockout , Models, Animal , Nervous System Diseases/physiopathology , Stroke/physiopathology
10.
Neurosci Lett ; 417(1): 50-4, 2007 Apr 24.
Article En | MEDLINE | ID: mdl-17346883

Numerous epidemiology studies have shown protective effects of hormone therapy (HT) on chronic neurological diseases. We have proposed that some of the neuroprotective effects of estrogen are mediated by apolipoprotein E (apoE). Polymorphisms of receptors for apoE modify the risk for dementia. To our knowledge, no reports exist showing CNS effects of estrogen replacement on members of the low-density lipoprotein receptor family. The current study focused on the effect of estradiol-17beta (E2) replacement on protein expression of two members of the receptor family, the low-density lipoprotein receptor (LDL-r) and low-density lipoprotein receptor related protein (LRP) in ovariectomized mice. Five days of E2 replacement significantly increased LRP expression in the hippocampus, olfactory bulb and neocortex but not in cerebellum. In contrast, E2 treatment decreased LDL-r protein expression in olfactory bulb. HT modification of both apoE and LRP could have wide-spread effects on cellular function given LRP's manifold signaling functions.


Brain/drug effects , Estradiol/pharmacology , Hormone Replacement Therapy , Neurodegenerative Diseases/drug therapy , Neuroprotective Agents/pharmacology , Receptors, LDL/drug effects , Animals , Apolipoproteins E/metabolism , Brain/anatomy & histology , Brain/metabolism , Down-Regulation/drug effects , Down-Regulation/physiology , Estradiol/therapeutic use , Female , Low Density Lipoprotein Receptor-Related Protein-1/drug effects , Low Density Lipoprotein Receptor-Related Protein-1/metabolism , Mice , Mice, Inbred C57BL , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/prevention & control , Neuroprotective Agents/therapeutic use , Olfactory Bulb/drug effects , Olfactory Bulb/metabolism , Receptors, LDL/metabolism , Up-Regulation/drug effects , Up-Regulation/physiology
11.
Brain Res ; 1137(1): 78-83, 2007 Mar 16.
Article En | MEDLINE | ID: mdl-17239830

Previous studies from our laboratory suggest that apolipoprotein (apoE), a lipid transporting protein, facilitates olfactory nerve regeneration. We have shown that apoE is enriched in the olfactory nerve and around the glomeruli of the olfactory bulb (OB). The studies reported herein were undertaken to identify possible sources of apoE in the olfactory epithelium (OE). Immunoblotting results revealed apoE expression in the OE of wild-type (WT) mice, but not in apoE deficient/knockout (KO) mice. Immunohistochemical studies revealed that the perikarya and processes of sustentacular (Sus) cells expressed apoE-like immunoreactivity. Minimal neuronal apoE immunostaining was seen, although apoE was observed in the interstial spaces between olfactory receptor neurons (ORN). Substantial apoE-like immunoreactivity was localized to the endfeet and terminal process of Sus cells surrounding the basal cells. Double labeling immunocytochemical studies confirmed that the cell bodies and endfeet of Sus cells expressed high levels of apoE. The endothelial cells of blood vessels were intensely stained for apoE in the lamina propria. Cells forming Bowman's gland also immunostained for apoE. The apoE staining in the nerve fascicles was less intense, but was uniformly distributed throughout the core of the nerve bundles. Heavily stained cells, probably ensheathing glia, surrounded the nerve fascicles. These results revealed that apoE is expressed in the adult OE and lamina propria at strategic locations where it could facilitate the differentiation, maturation and axonal growth of the ORN, perhaps by recycling lipids from degenerating ORN for use by growing axons.


Apolipoproteins E/metabolism , Gene Expression Regulation/genetics , Olfactory Mucosa/metabolism , Animals , Apolipoproteins E/deficiency , Immunohistochemistry , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Tissue Proteins , Olfactory Receptor Neurons/metabolism
12.
Exp Gerontol ; 42(1-2): 54-63, 2007.
Article En | MEDLINE | ID: mdl-16837159

The effects of ovarian hormone on neuronal growth and function are well known. However, equally important, but often neglected, are ovarian hormone effects on glia. Our in vivo and in vitro studies show that estradiol modifies both neuronal growth and glial activity and these effects are tightly linked. Estradiol stimulates neurite growth and the release of the glial apolipoprotein E (apoE) in culture studies. Estradiol-stimulated neurite growth in these cultures requires apoE. Estradiol replacement in ovariectomized mice transiently increases the expression of apoE, the low density lipoprotein receptor related protein (LRP) and synaptophysin throughout the brain. Continuous estradiol replacement over two months loses effect on apoE, LRP, and synaptophysin and suppresses reactive gliosis. Estrous cycle variation of glial activation (GFAP) and apoE are not identical. We propose that estradiol (and other ovarian hormones) functions as a zeitgeber to co-ordinate neuronal-glial interactions. Co-ordination assures temporally appropriate excitatory and inhibitory interactions between glia and neurons. With aging and the loss of ovarian cyclicity, some of this co-ordination must be diminished. These observations present significant clinical implications. Approaches to hormone therapy (HT), for diminishing the risk of chronic neurological diseases, need to consider the temporal nature of ovarian hormones in brain repair and plasticity. Moreover, approaches must consider apoE genotype. The neuroprotective effects of HT in numerous chronic age-related diseases may represent effective co-ordination of repair processes rather than direct disease-specific actions. Moreover, the role of glial-derived proteins in neuroprotection should not be ignored.


Apolipoproteins E/metabolism , Astrocytes/metabolism , Estradiol/physiology , Nerve Regeneration/physiology , Neurons/physiology , Adult , Animals , Estrogen Replacement Therapy , Female , Humans , Mice , Middle Aged , Neurodegenerative Diseases/drug therapy , Neuronal Plasticity/physiology , Postmenopause/physiology
13.
Exp Neurol ; 197(1): 197-205, 2006 Jan.
Article En | MEDLINE | ID: mdl-16226751

The current study examined the effect of long-term estradiol replacement in ovariectomized mice. Estradiol-17beta (E2) pellets or vehicle pellets were implanted at the time of ovariectomy (OVX) in young adult female mice. Five mice from each group were sacrificed at 5, 14, 28 and 49 days after OVX and pellet replacement. Western blotting of homogenates from somatosensory cortex, hippocampus, olfactory bulb and cerebellum was performed to obtain concentrations of glial fibrillary acidic protein (GFAP), apolipoprotein E (apoE) and synaptophysin (SYN). At 5 days after OVX, GFAP levels were not affected by E2 replacement. In contrast to GFAP, synaptophysin and apoE concentrations were significantly elevated by 15% and 25%, respectively, in the E2-replaced group compared to the vehicle-replaced group at 5 days but by 14 days concentrations were equivalent. Late in the time course of this study, at 49 days, GFAP concentrations were higher in the E2-deprived mice but did not increase in the E2-replaced group. Immunocytochemistry for GFAP confirmed this observation. Of note was that these effects occurred in all four brain regions measured. These observations suggest that estradiol is able to suppress reactive gliosis. In addition, E2 replacement in OVX mice is associated with transiently higher levels of apoE and synaptophysin.


Apolipoproteins E/biosynthesis , Brain Chemistry/drug effects , Estradiol/pharmacology , Estrogen Replacement Therapy , Glial Fibrillary Acidic Protein/antagonists & inhibitors , Neuroglia/metabolism , Synaptophysin/biosynthesis , Animals , Blotting, Western , Cerebellum/drug effects , Cerebellum/metabolism , Data Interpretation, Statistical , Estradiol/blood , Female , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry , Mice , Mice, Inbred C57BL , Neocortex/drug effects , Neocortex/metabolism , Neuroglia/drug effects , Ovariectomy
14.
Brain Res ; 1041(1): 87-94, 2005 Apr 11.
Article En | MEDLINE | ID: mdl-15804503

Apolipoprotein E (apoE), a lipid transporting protein, is extensively expressed in the primary olfactory pathway, but its function is unknown. We previously reported increased apoE levels in the olfactory bulb (OB) following olfactory epithelium (OE) lesion in mice, and hypothesized that apoE may play a vital role in olfactory nerve (ON) regeneration. To directly test this hypothesis, we examined the rate of ON regeneration following OE lesion in apoE deficient/knockout (KO) and wild-type (WT) mice. OE was lesioned in 2- to 3-month-old mice by intranasal irrigation with Triton X-100 (TX). OB were collected at 0, 3, 7, 21, 42, and 56 days post-lesion. OB recovery was measured by both immunoblotting and immunohistochemical analysis of growth cone associated protein (GAP) 43 and olfactory marker protein (OMP). The results revealed that (1) OMP recovery in the OB was significantly slower in apoE KO compared to WT mice; (2) recovery of glomerular area was similarly slower; and (3) GAP43 increases and return to prelesion levels in the OB were slower in KO mice. Together, these results show that olfactory nerve regeneration is significantly slower in KO mice as compared to WT mice, suggesting apoE facilitates olfactory nerve regeneration.


Apolipoproteins E/physiology , Nerve Regeneration/physiology , Olfactory Nerve/physiology , Olfactory Pathways/metabolism , Animals , Apolipoproteins E/deficiency , GAP-43 Protein/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Degeneration/chemically induced , Nerve Tissue Proteins/metabolism , Octoxynol , Olfactory Marker Protein , Olfactory Mucosa/drug effects , Olfactory Mucosa/physiology
15.
Behav Brain Res ; 150(1-2): 1-7, 2004 Apr 02.
Article En | MEDLINE | ID: mdl-15033273

Apolipoprotein E (apoE), a lipid transporting protein, has been shown to play a vital role in nerve repair and remodeling. Since the olfactory system is in a continuous state of remodeling, the present study tested the hypothesis that apoE is required for normal functioning of the olfactory system. Olfactory behavior of wild-type (WT) and apoE-deficient (apoE KO) mice was assessed by using three standard olfactory tests: (1) the buried food pellet (BFP) test; (2) the odor choice (OC) test; and (3) the odor cued taste avoidance (OCTA) test. ApoE KO mice performed poorly in all the three tests as compared to WT mice, although they learned the tasks at a rate comparable to WT mice. ApoE KO mice had a significantly longer latency to find the buried pellet than WT mice. In the OC experiment, apoE KO mice did not differentiate water from an odorant solution. Furthermore, in the OCTA test the apoE KO mice were significantly less successful than WT mice at avoiding water containing an odorant and a bad tastant. These data demonstrate that apoE deficiency in apoE KO mice leads to a deficit in olfactory function, suggesting an important role for apoE in the olfactory system.


Apolipoproteins E/genetics , Apolipoproteins E/physiology , Smell/genetics , Smell/physiology , Animals , Avoidance Learning , Behavior, Animal/physiology , Cues , Mice , Mice, Inbred C57BL , Mice, Knockout , Odorants
16.
Endocrinology ; 145(7): 3065-73, 2004 Jul.
Article En | MEDLINE | ID: mdl-15033916

Literature review suggests a close relationship between estrogen and apolipoprotein E (ApoE) in the central nervous system. Epidemiology studies show that estrogen replacement therapy (ERT) decreases the morbidity from several chronic neurological diseases. Alleles of ApoE modify the risk for and progression of the same diseases. ApoE levels in the rodent brain vary during the estrous cycle and increase after 17beta-estradiol administration. Both estradiol and ApoE3, the most common isoform of human ApoE, increase the extent of neurite outgrowth in culture. Combined, these observations suggest a common mechanism whereby estrogen may increase ApoE levels to facilitate neurite growth. We tested this hypothesis by characterizing the effects of estradiol and ApoE isoforms on neurite outgrowth in cultured adult mouse cortical neurons. Estradiol increased ApoE levels and neurite outgrowth. ApoE2 increased neurite length more so than ApoE3 in the presence of estradiol. Estradiol had no effect on neurite outgrowth from mice lacking the ApoE gene or when only ApoE4, the isoform of ApoE that is associated with increased risk of neurological disease, was exogenously supplied. Cultures from mice transgenic for human ApoE3 or ApoE4 showed the same isoform-specific effect. Neuronal internalization of recombinant human ApoE3 was greater than ApoE4, and ApoE3 was more effective than ApoE4 in facilitating neuronal uptake of a fatty acid. We conclude that estradiol facilitates neurite growth through an ApoE-dependent mechanism. The effects of ERT on chronic neurological diseases may vary with ApoE genotype. The clinical use of ERT may require ApoE genotyping for optimal efficacy.


Apolipoproteins E/genetics , Apolipoproteins E/pharmacokinetics , Estradiol/pharmacology , Neurites/drug effects , Neurites/metabolism , Age Factors , Animals , Apolipoproteins E/chemistry , Cells, Cultured , Cerebral Cortex/cytology , Dose-Response Relationship, Drug , Female , Isomerism , Lipids/pharmacokinetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Neurons/drug effects , Neurons/metabolism , Neurons/ultrastructure
17.
Brain Res ; 928(1-2): 96-105, 2002 Feb 22.
Article En | MEDLINE | ID: mdl-11844476

The apolipoprotein E4 (apoE4) genotype is a major risk factor for Alzheimer's disease (AD); however, the mechanism is unknown. We previously demonstrated that apoE isoforms differentially modulated neurite outgrowth in embryonic neurons and in neuronal cell lines. ApoE3 increased neurite outgrowth whereas apoE4 decreased outgrowth, suggesting that apoE4 may directly affect neurons in the brain. In the present study we examined the effects of apoE on neurite outgrowth from cultured adult mouse cortical neurons to examine if adult neurons respond the same way that embryonic cells do. The results from this study demonstrated that (1) cortical neurons derived from adult apoE-gene knockout (apoE KO) mice have significantly shorter neurites than neurons from adult wild-type (WT) mice; (2) incubation of cortical neurons from adult apoE KO mice with human apoE3 increased neurite outgrowth, whereas human apoE4 decreased outgrowth in a dose-dependent fashion; (3) the isoform specific effects were abolished by incubation of the neurons with either receptor associated protein (RAP) or lactoferrin, both of which block the interaction of apoE-containing lipoproteins with the low-density lipoprotein receptor-related protein (LRP). These data suggest a potential mechanism whereby apoE4 may play a role in regenerative failure and accelerate the development of AD.


Alzheimer Disease/metabolism , Apolipoproteins E/pharmacology , Cell Differentiation/drug effects , Cerebral Cortex/drug effects , Low Density Lipoprotein Receptor-Related Protein-1/drug effects , Neurites/drug effects , Alzheimer Disease/physiopathology , Animals , Apolipoprotein E3 , Apolipoprotein E4 , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Cell Culture Techniques , Cell Differentiation/physiology , Cells, Cultured , Cerebral Cortex/growth & development , Cerebral Cortex/metabolism , Culture Media, Conditioned/pharmacology , Dose-Response Relationship, Drug , Female , Immunohistochemistry , LDL-Receptor Related Protein-Associated Protein/metabolism , LDL-Receptor Related Protein-Associated Protein/pharmacology , Lactoferrin/pharmacology , Low Density Lipoprotein Receptor-Related Protein-1/metabolism , Male , Mice , Mice, Knockout , Nerve Regeneration/drug effects , Nerve Regeneration/physiology , Neurites/metabolism , Neurites/ultrastructure , Neuronal Plasticity/drug effects , Neuronal Plasticity/physiology
...